Mirum Pharmaceuticals, Inc. 4

SVP, Global Controller Jolanda Howe sold 658 shares of Mirum Pharmaceuticals, Inc. common stock at $100.00 per share under a Rule 10b5-1 plan.

On 2026-09-02, Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, Inc., sold 658 shares of common stock at $100.00 per share for total proceeds of approximately $65,800 under a pre-arranged Rule 10b5-1 trading plan, reducing her direct holdings to 616 shares. Based on the transaction price, her remaining stake is valued at roughly $61,600, and the sale appears to be a relatively small, planned diversification rather than a large, discretionary disposition.

Filing Facts

CIK

1759425

Ticker

MIRM

Form

4

Source Type

fda

Accession

0001974200-26-000013

Alert Tier

5